SEO URLwww.firestrike.ai/deals/ignite-proteomics-aditx-acquisition-2026

acquisitionAnnounced · Mar 13, 2026Precision OncologySource · Unverified ReportsArticle · Factual

Ignite Proteomics · Aditx

Aditx acquires Ignite Proteomics

David Najork · Founding Software Engineer

Published Apr 29, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$36M

Target

Ignite Proteomics

NASDAQ: IGNITE

Acquirer

Aditx

Full Acquisition

Status

Announced

Aditx agreed to acquire Ignite Proteomics. Reported deal value: $36M. Status: Announced. Sector: Precision Oncology. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-03-13. Figures and status may change as filings and press coverage update.

Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection Ignite plans to launch a new program in 20 26 supporting treatment selection for more than 600,000 people in the United States living with metastatic cancer and limited therapeutic options

Deal timeline

Announced

Mar 13, 2026 · stocktitan.net

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Precision Oncology with a reported deal value of $36M. Figures and status may change as sources update.

Sources: stocktitan.net · Primary article · FireStrike proprietary index